Skip to Main Content

Research Labs and Programs

University of Miami Leonard M. Miller School of Medicine

Research Programs

  • Florida-Puerto Rico Collaboration to Reduce Stroke Disparities

    The Florida Puerto Collaboration to Reduce Stroke Disparities (FL-PR CReSD) aims to address stroke disparities among African Americans and Hispanics and to identify the best approaches to eliminate stroke care disparities in these groups.

Research Labs

  • Ajdic Lab

    Our research is focused on understanding bacterial biofilm infection, especially skin and wound infection. Specifically, we study microbiomes of wounds, including chronic wounds. Our research has also expanded into the field of antimicrobial peptides that target skin and wound infection. This is crucial early-stage research aimed at developing novel antibiofilm therapies.

  • Beurel Lab

    Our research uses a three-pronged approach to understand how the immune system modulates stress responses and susceptibility to depression.

  • Chaudhari Lab

    The Chaudhari lab studies cellular physiology of the taste system in the peripheral detectors, the taste buds, and in the sensory neurons that innervate them. We use a variety of tools – from single-cell RNA sequencing, to confocal microscopy, to in vivo Ca2+ imaging in anesthetized mice.

  • Daunert Lab

    Our group genetically engineers living cells and proteins for environmental detection, molecular sensing, molecular diagnostics, point-of-care tests, biomarker identification, and drug delivery. Additionally, the research of the group focuses on the development of targeted and responsive drug delivery systems.

  • Davis Lab

    The Davis laboratory has extensive experience and expertise in the evaluation of wound healing agents using various in vitro and in vivo preclinical models.

  • Deo Lab

    We are a bionanotechnology research lab in the Biochemistry & Molecular Biology Department of the University of Miami Miller School of Medicine located in Miami, Florida. We develop novel biotechnology tools employing luminescent proteins and inorganic probes.

  • Dhar Lab

    Dr. Dhar’s team develop macromolecular technologies, which are engineered to nanoparticles and targeted to the mitochondria of cells and they have chemistry-based programs on combination therapy for various cancers.

  • Domínguez-Bendala Lab

    The main lines of research in the Domínguez-Bendala Lab revolve around the development of regenerative strategies for type 1 diabetes, including stem cell differentiation into insulin-producing β-cells and islet regeneration.

  • Goldberg Lab

    The Goldberg Lab uses tools from epidemiology, biostatistics, health services research, and empirical bioethics to study and improve outcomes among patients with chronic liver disease and cirrhosis, patients pre- and post-liver transplantation, and the broader population of patients waitlisted for a solid organ transplant.

  • Jones/Weiss Lab

    Our research focuses on bio-behavioral interventions that promote HIV risk reduction and treatment adherence in sub-Saharan Africa, South America, India, and the U.S. We’re working to discover the various factors that influence optimal health outcomes in people living with HIV.

  • Jozic Lab

    The primary goal of our laboratory is to understand the role caveolins and caveolae play in cutaneous physiology and pathophysiology.

  • Lassance-Soares Lab

    Dr. Lassance-Soares’ Lab studies cellular and molecular mechanism underlying neovascularization and endothelial dysfunction, with a strong focus in translational research. Specifically, Dr. Lassance-Soares interest is to enhance angiogenesis and arteriogenesis in pre-clinical model of hindlimb ischemia.

  • Lembix Lab

    We use different kinds of strategies to look for molecular targets to promote nerve regeneration. Kinases regulate most aspects of cell function. As they are very important in cancer, there are many drugs and compounds as well as cDNA and RNAi libraries that can be used to perturb the Kinome. Neuroscientists should exploit these resources.

  • Lindau Lab

    The central project in our laboratory is currently the investigation of the molecular machine, which releases many neurotransmitters and hormones in the body.

  • Munson Lab

    The molecular and cellular biology of the bactericidal pore-forming protein Perforin-2 (MPEG1) is a major area of emphasis within the Munson laboratory. Concurrently we are using multidisciplinary approaches to discover and characterize bacterial effectors that subvert or inhibit the bactericidal activity of Perforin-2 with a particular emphasis on enteric and multidrug resistant pathogens.

  • Pahwa Lab

    Dr. Pahwa’s expertise is in Immunology with a focus on immune development and HIV immunopathogenesis across the life span from childhood to aging.

  • Pastori Lab

    Dr. Pastori’s overall research interests focus on the development of translational molecular strategies for the advancement of type 1 diabetes treatments, including regenerative approaches for pancreatic islets and beta-cells.

  • Paus Lab

    Dr Paus’ laboratory focuses on the biology and pathology of human hair follicles, covering a wide range of topics from hair growth control, pigmentation, neuroendocrinology, neurobiology and immunology of the hair follicle via the pathobiology of alopecia areata, lichen planopilaris, and frontal fibrosing alopecia to novel management strategies for chemotherapy-induced alopecia and hair graying.

  • Starke Lab

    The goal of the Starke laboratory is to study cerebrovascular diseases from a clinical, translational, therapeutic, and basic science prospective. Our laboratory is uniquely suited to investigate cerebrovascular disease using a multipronged approach consisting of cell culture, experimental aneurysm models, advanced imaging modalities and clinical studies.

  • Stone Lab

    Translational genomics (Skinomics), skin fibrosis, chronic wound healing, precision medicine.

  • Toborek Lab

    The main research interest in my laboratory is focused on the vascular effects of HIV infection with the focus on the alterations of the blood-brain barrier (BBB).

  • Tuesta Lab

    The Tuesta Lab is interested in understanding the epigenetic mechanisms underpinning activation of microglia and how persistent activation of these cells by chemotherapeutic agents can drive cognitive and attentional deficits in cancer patients receiving chemotherapy.

  • Weiss Lab

    Welcome to the University of Miami Thyroid Study Unit, a leading research facility dedicated to the clinical and laboratory investigation of inherited and rare thyroid disorders. Our mission is to advance understanding, diagnosis, and treatment in this field through both clinical studies and basic science research.

  • Zeier Lab

    Our research focuses on neurological disease and its underlying causes to develop promising new therapies. We create induced pluripotent stem cells (iPSCs) — which allow us to study human neurons — to model neurodevelopmental and neurodegenerative diseases using 2D neuronal cultures and 3D cerebral brain organoids. This enables us to investigate how specific mutations lead to these diseases.